Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.805
Filter
1.
PeerJ ; 12: e17394, 2024.
Article in English | MEDLINE | ID: mdl-38827296

ABSTRACT

The increasing frequency of zoonotic spillover events and viral mutations in low and middle-income countries presents a critical global health challenge. Contributing factors encompass cultural practices like bushmeat consumption, wildlife trade for traditional medicine, habitat disruption, and the encroachment of impoverished settlements onto natural habitats. The existing "vaccine gap" in many developing countries exacerbates the situation by allowing unchecked viral replication and the emergence of novel mutant viruses. Despite global health policies addressing the root causes of zoonotic disease emergence, there is a significant absence of concrete prevention-oriented initiatives, posing a potential risk to vulnerable populations. This article is targeted at policymakers, public health professionals, researchers, and global health stakeholders, particularly those engaged in zoonotic disease prevention and control in low and middle-income countries. The article underscores the importance of assessing potential zoonotic diseases at the animal-human interface and comprehending historical factors contributing to spillover events. To bridge policy gaps, comprehensive strategies are proposed that include education, collaborations, specialized task forces, environmental sampling, and the establishment of integrated diagnostic laboratories. These strategies advocate simplicity and unity, breaking down barriers, and placing humanity at the forefront of addressing global health challenges. Such a strategic and mental shift is crucial for constructing a more resilient and equitable world in the face of emerging zoonotic threats.


Subject(s)
Developing Countries , Zoonoses , Humans , Animals , Zoonoses/prevention & control , Zoonoses/virology , Zoonoses/epidemiology , Zoonoses/transmission , Mutation , Health Policy/legislation & jurisprudence , Global Health , Communicable Diseases, Emerging/prevention & control , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/virology , Communicable Diseases, Emerging/transmission
3.
Sci Rep ; 14(1): 10431, 2024 05 07.
Article in English | MEDLINE | ID: mdl-38714841

ABSTRACT

Reverse zoonotic respiratory diseases threaten great apes across Sub-Saharan Africa. Studies of wild chimpanzees have identified the causative agents of most respiratory disease outbreaks as "common cold" paediatric human pathogens, but reverse zoonotic transmission pathways have remained unclear. Between May 2019 and August 2021, we conducted a prospective cohort study of 234 children aged 3-11 years in communities bordering Kibale National Park, Uganda, and 30 adults who were forest workers and regularly entered the park. We collected 2047 respiratory symptoms surveys to quantify clinical severity and simultaneously collected 1989 nasopharyngeal swabs approximately monthly for multiplex viral diagnostics. Throughout the course of the study, we also collected 445 faecal samples from 55 wild chimpanzees living nearby in Kibale in social groups that have experienced repeated, and sometimes lethal, epidemics of human-origin respiratory viral disease. We characterized respiratory pathogens in each cohort and examined statistical associations between PCR positivity for detected pathogens and potential risk factors. Children exhibited high incidence rates of respiratory infections, whereas incidence rates in adults were far lower. COVID-19 lockdown in 2020-2021 significantly decreased respiratory disease incidence in both people and chimpanzees. Human respiratory infections peaked in June and September, corresponding to when children returned to school. Rhinovirus, which caused a 2013 outbreak that killed 10% of chimpanzees in a Kibale community, was the most prevalent human pathogen throughout the study and the only pathogen present at each monthly sampling, even during COVID-19 lockdown. Rhinovirus was also most likely to be carried asymptomatically by adults. Although we did not detect human respiratory pathogens in the chimpanzees during the cohort study, we detected human metapneumovirus in two chimpanzees from a February 2023 outbreak that were genetically similar to viruses detected in study participants in 2019. Our data suggest that respiratory pathogens circulate in children and that adults become asymptomatically infected during high-transmission times of year. These asymptomatic adults may then unknowingly carry the pathogens into forest and infect chimpanzees. This conclusion, in turn, implies that intervention strategies based on respiratory symptoms in adults are unlikely to be effective for reducing reverse zoonotic transmission of respiratory viruses to chimpanzees.


Subject(s)
Common Cold , Pan troglodytes , Animals , Humans , Child , Female , Male , Child, Preschool , Common Cold/epidemiology , Common Cold/virology , Adult , Uganda/epidemiology , Prospective Studies , Zoonoses/epidemiology , Zoonoses/virology , COVID-19/epidemiology , COVID-19/virology , COVID-19/transmission , Ape Diseases/epidemiology , Ape Diseases/virology , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/virology , Respiratory Tract Infections/veterinary , Rhinovirus/isolation & purification , Rhinovirus/genetics , SARS-CoV-2/isolation & purification , Incidence
4.
Nat Commun ; 15(1): 4171, 2024 May 16.
Article in English | MEDLINE | ID: mdl-38755147

ABSTRACT

Human Ebola virus (EBOV) outbreaks caused by persistent EBOV infection raises questions on the role of zoonotic spillover in filovirus epidemiology. To characterise filovirus zoonotic exposure, we collected cross-sectional serum samples from bushmeat hunters (n = 498) in Macenta Prefecture Guinea, adjacent to the index site of the 2013 EBOV-Makona spillover event. We identified distinct immune signatures (20/498, 4.0%) to multiple EBOV antigens (GP, NP, VP40) using stepwise ELISA and Western blot analysis and, live EBOV neutralisation (5/20; 25%). Using comparative serological data from PCR-confirmed survivors of the 2013-2016 EBOV outbreak, we demonstrated that most signatures (15/20) were not plausibly explained by prior EBOV-Makona exposure. Subsequent data-driven modelling of EBOV immunological outcomes to remote-sensing environmental data also revealed consistent associations with intact closed canopy forest. Together our findings suggest exposure to other closely related filoviruses prior to the 2013-2016 West Africa epidemic and highlight future surveillance priorities.


Subject(s)
Antibodies, Viral , Ebolavirus , Hemorrhagic Fever, Ebola , Humans , Animals , Guinea/epidemiology , Ebolavirus/immunology , Ebolavirus/isolation & purification , Hemorrhagic Fever, Ebola/epidemiology , Hemorrhagic Fever, Ebola/immunology , Hemorrhagic Fever, Ebola/virology , Hemorrhagic Fever, Ebola/blood , Hemorrhagic Fever, Ebola/transmission , Adult , Male , Antibodies, Viral/blood , Antibodies, Viral/immunology , Middle Aged , Zoonoses/virology , Zoonoses/epidemiology , Zoonoses/transmission , Female , Cross-Sectional Studies , Disease Outbreaks , Young Adult , Aged , Enzyme-Linked Immunosorbent Assay , Viral Zoonoses/epidemiology , Viral Zoonoses/transmission , Viral Zoonoses/virology , Antigens, Viral/immunology
5.
Adv Exp Med Biol ; 1451: 1-20, 2024.
Article in English | MEDLINE | ID: mdl-38801568

ABSTRACT

Monkeypox (Mpox) is a zoonotic disease caused by a virus (monkeypox virus-MPV) belonging to the Poxviridae family. In humans, the disease has an incubation period of 5-21 days and then progresses in two phases, the prodromal phase and the rash phase. The prodromal phase is characterized by non-specific symptoms such as fever, muscle pain, malaise, lymphadenopathy, headache, and chills. Skin lesions appear in the rash phase of the disease. These lesions progress through different stages (macules, papules, vesicles, and pustules). In May 2022, WHO reported an outbreak of human Mpox in several countries which were previously Mpox-free. As per the CDC report of March 01, 2023, a total of 86,231 confirmed cases of Mpox and 105 deaths have been reported from 110 countries and territories across the globe. Notably, more than 90% of these countries were reporting Mpox for the first time. The phylogenetic analysis revealed that this outbreak was associated with the virus from the West African clade. However, most of the cases in this outbreak had no evidence of travel histories to MPV-endemic countries in Central or West Africa. This outbreak was primarily driven by the transmission of the virus via intimate contact in men who have sex with men (MSM). The changing epidemiology of Mpox raised concerns about the increasing spread of the disease in non-endemic countries and the urgent need to control and prevent it. In this chapter, we present all the documented cases of Mpox from 1970 to 2023 and discuss the past, present, and future of MPV.


Subject(s)
Disease Outbreaks , Monkeypox virus , Mpox (monkeypox) , Animals , Humans , Monkeypox virus/genetics , Monkeypox virus/pathogenicity , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/transmission , Mpox (monkeypox)/virology , Phylogeny , Zoonoses/epidemiology , Zoonoses/virology , Zoonoses/transmission
6.
Adv Exp Med Biol ; 1451: 21-33, 2024.
Article in English | MEDLINE | ID: mdl-38801569

ABSTRACT

In the last 4 years, the world has experienced two pandemics of bat-borne viruses. Firstly, in 2019 the SARS-CoV-2 pandemic started and has been causing millions of deaths around the world. In 2022, a Monkeypox pandemic rose in various countries of the world. Those pandemics have witnessed movements and initiatives from healthcare and research institutions to establish a worldwide understanding to battle any future pandemics and biological threats. One Health concept is a modern, comprehensive, unifying ways to improve humans, animals, and ecosystems' health. This concept shows how much they are intertwined and related to one another, whether it is an environmental, or a pathological relation. This review aims to describe Poxviridae and its impact on the One Health concept, by studying the underlying causes of how poxviruses can affect the health of animals, humans, and environments. Reviewing the effect of disease transmission between animal to human, human to human, and animal to animal with pox viruses as a third party to achieve a total understanding of infection and viral transmission. Thus, contributing to enhance detection, diagnosis, research, and treatments regarding the application of One Health.


Subject(s)
One Health , Poxviridae Infections , Poxviridae , Humans , Animals , Poxviridae Infections/virology , Poxviridae Infections/transmission , Poxviridae Infections/epidemiology , Poxviridae/physiology , Poxviridae/pathogenicity , Poxviridae/genetics , COVID-19/virology , COVID-19/transmission , COVID-19/epidemiology , Zoonoses/virology , Zoonoses/transmission , Zoonoses/epidemiology , SARS-CoV-2/pathogenicity , SARS-CoV-2/physiology , Pandemics , Viral Zoonoses/transmission , Viral Zoonoses/virology , Viral Zoonoses/epidemiology
7.
Adv Exp Med Biol ; 1451: 75-90, 2024.
Article in English | MEDLINE | ID: mdl-38801572

ABSTRACT

The current multicounty outbreak of monkeypox virus (MPXV) posed an emerging and continued challenge to already strained public healthcare sector, around the globe. Since its first identification, monkeypox disease (mpox) remained enzootic in Central and West African countries where reports of human cases are sporadically described. Recent trends in mpox spread outside the Africa have highlighted increased incidence of spillover of the MPXV from animal to humans. While nature of established animal reservoirs remained undefined, several small mammals including rodents, carnivores, lagomorphs, insectivores, non-human primates, domestic/farm animals, and several species of wildlife are proposed to be carrier of the MPXV infection. There are established records of animal-to-human (zoonotic) spread of MPXV through close interaction of humans with animals by eating bushmeat, contracting bodily fluids or trading possibly infected animals. In contrast, there are reports and increasing possibilities of human-to-animal (zooanthroponotic) spread of the MPXV through petting and close interaction with pet owners and animal care workers. We describe here the rationales and molecular factors which predispose the spread of MPXV not only amongst humans but also from animals to humans. A range of continuing opportunities for the spread and evolution of MPXV are discussed to consider risks beyond the currently identified groups. With the possibility of MPXV establishing itself in animal reservoirs, continued and broad surveillance, investigation into unconventional transmissions, and exploration of spillover events are warranted.


Subject(s)
Monkeypox virus , Mpox (monkeypox) , Zoonoses , Animals , Mpox (monkeypox)/transmission , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/virology , Humans , Monkeypox virus/pathogenicity , Monkeypox virus/genetics , Zoonoses/transmission , Zoonoses/virology , Zoonoses/epidemiology , Disease Reservoirs/virology , Disease Outbreaks , Animals, Wild/virology
8.
Adv Exp Med Biol ; 1451: 171-181, 2024.
Article in English | MEDLINE | ID: mdl-38801578

ABSTRACT

Despite being common worldwide, parapoxvirus infections are regarded as neglected zoonoses because their incidence is either unknown or grossly overestimated. In ruminants all throughout the world, parapoxvirus produces oral lesions and infectious pustular dermatitis. The pathogen is typically spread directly via items contaminated with parapoxvirus and indirectly via a near contact with dermatological lesions that contain the virus on affected animals. Animals infected with the parapoxvirus typically exhibit no clinical symptoms, and the mode of parapoxvirus transmission is occasionally unclear. For accurate etiological diagnosis and appropriate therapy of patients affected by zoonotic infections, the significance of adopting a "One Health" approach and cross-sector collaboration between human and veterinary medicine should be emphasized. The causative pathogen of ecthyma contagiosum in general people is the orf virus, which mostly infects various animals, either pets or wildlife species. The illness primarily affects minute wild ruminants, sheep, cattle, deer, and goats, and it can spread to people through contact with infected animals or contaminated meats anywhere in the world. Taxonomically speaking, the virus belongs to the parapoxvirus genus. Thus pathogen can be detected from crusts for a very long period (several months to several years), and the virus is found to be resistant to inactivation with a hot or dry atmosphere. In immunocompetent individuals, the lesions often go away on their own with a period as long 2 months. Nevertheless, it necessitates the applying of diverse strategies, such as antiviral, immunological modulator, or modest surgical excisions in immunosuppressed patients. The interaction of the virus with various host populations aids in the development of a defense mechanism against the immune system. The parapoxvirus illness in humans is covered in this chapter. The orf illness, a significant known human parapoxvirus infection, is given specific attention.


Subject(s)
Ecthyma, Contagious , Orf virus , Ecthyma, Contagious/virology , Ecthyma, Contagious/transmission , Ecthyma, Contagious/diagnosis , Ecthyma, Contagious/epidemiology , Animals , Humans , Orf virus/pathogenicity , Orf virus/isolation & purification , Orf virus/genetics , Zoonoses/virology , Zoonoses/transmission , Parapoxvirus/genetics , Parapoxvirus/isolation & purification
9.
Adv Exp Med Biol ; 1451: 355-368, 2024.
Article in English | MEDLINE | ID: mdl-38801590

ABSTRACT

Monkeypox (mpox), a zoonotic disease caused by the monkeypox virus (MPXV), poses a significant public health threat with the potential for global dissemination beyond its endemic regions in Central and West Africa. This study explores the multifaceted aspects of monkeypox, covering its epidemiology, genomics, travel-related spread, mass gathering implications, and economic consequences. Epidemiologically, mpox exhibits distinct patterns, with variations in age and gender susceptibility. Severe cases can arise in immunocompromised individuals, underscoring the importance of understanding the factors contributing to its transmission. Genomic analysis of MPXV highlights its evolutionary relationship with the variola virus and vaccinia virus. Different MPXV clades exhibit varying levels of virulence and transmission potential, with Clade I associated with higher mortality rates. Moreover, the role of recombination in MPXV evolution remains a subject of interest, with implications for understanding its genetic diversity. Travel and mass gatherings play a pivotal role in the spread of monkeypox. The ease of international travel and increasing globalization have led to outbreaks beyond African borders. The economic ramifications of mpox outbreaks extend beyond public health. Direct treatment costs, productivity losses, and resource-intensive control efforts can strain healthcare systems and economies. While vaccination and mitigation strategies have proven effective, the cost-effectiveness of routine vaccination in non-endemic countries remains a subject of debate. This study emphasizes the role of travel, mass gatherings, and genomics in its spread and underscores the economic impacts on affected regions. Enhancing surveillance, vaccination strategies, and public health measures are essential in controlling this emerging infectious disease.


Subject(s)
Disease Outbreaks , Global Health , Monkeypox virus , Mpox (monkeypox) , Travel , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/virology , Mpox (monkeypox)/transmission , Humans , Disease Outbreaks/prevention & control , Monkeypox virus/genetics , Monkeypox virus/pathogenicity , Animals , Rare Diseases/epidemiology , Rare Diseases/genetics , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/transmission , Communicable Diseases, Emerging/virology , Communicable Diseases, Emerging/prevention & control , Public Health , Female , Zoonoses/epidemiology , Zoonoses/transmission , Zoonoses/virology , Male
10.
Viruses ; 16(5)2024 04 26.
Article in English | MEDLINE | ID: mdl-38793568

ABSTRACT

The hepatitis E virus is a serious health concern worldwide, with 20 million cases each year. Growing numbers of autochthonous HEV infections in industrialized nations are brought on via the zoonotic transmission of HEV genotypes 3 and 4. Pigs and wild boars are the main animal reservoirs of HEV and play the primary role in HEV transmission. Consumption of raw or undercooked pork meat and close contact with infected animals are the most common causes of hepatitis E infection in industrialized countries. However, during the past few years, mounting data describing HEV distribution has led experts to believe that additional animals, particularly domestic ruminant species (cow, goat, sheep, deer, buffalo, and yak), may also play a role in the spreading of HEV. Up to now, there have not been enough studies focused on HEV infections associated with animal milk and the impact that they could have on the epidemiology of HEV. This critical analysis discusses the role of domestic ruminants in zoonotic HEV transmissions. More specifically, we focus on concerns related to milk safety, the role of mixed farming in cross-species HEV infections, and what potential consequences these may have on public health.


Subject(s)
Animals, Domestic , Hepatitis E virus , Hepatitis E , Milk , Ruminants , Zoonoses , Animals , Hepatitis E/transmission , Hepatitis E/veterinary , Hepatitis E/virology , Hepatitis E virus/genetics , Hepatitis E virus/isolation & purification , Milk/virology , Ruminants/virology , Zoonoses/virology , Zoonoses/transmission , Humans , Animals, Domestic/virology , Viral Zoonoses/transmission , Viral Zoonoses/virology , Goats/virology , Sheep/virology , Genotype
11.
Rev Med Virol ; 34(3): e2541, 2024 May.
Article in English | MEDLINE | ID: mdl-38743385

ABSTRACT

As the mankind counters the ongoing COVID-19 pandemic by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), it simultaneously witnesses the emergence of mpox virus (MPXV) that signals at global spread and could potentially lead to another pandemic. Although MPXV has existed for more than 50 years now with most of the human cases being reported from the endemic West and Central African regions, the disease is recently being reported in non-endemic regions too that affect more than 50 countries. Controlling the spread of MPXV is important due to its potential danger of a global spread, causing severe morbidity and mortality. The article highlights the transmission dynamics, zoonosis potential, complication and mitigation strategies for MPXV infection, and concludes with suggested 'one health' approach for better management, control and prevention. Bibliometric analyses of the data extend the understanding and provide leads on the research trends, the global spread, and the need to revamp the critical research and healthcare interventions. Globally published mpox-related literature does not align well with endemic areas/regions of occurrence which should ideally have been the scenario. Such demographic and geographic gaps between the location of the research work and the endemic epicentres of the disease need to be bridged for greater and effective translation of the research outputs to pubic healthcare systems, it is suggested.


Subject(s)
Bibliometrics , Humans , Disease Outbreaks/prevention & control , Animals , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/transmission , Mpox (monkeypox)/prevention & control , Mpox (monkeypox)/virology , COVID-19/transmission , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/virology , SARS-CoV-2 , Zoonoses/epidemiology , Zoonoses/virology , Zoonoses/transmission , Zoonoses/prevention & control , Pandemics/prevention & control
12.
Nat Commun ; 15(1): 3589, 2024 Apr 27.
Article in English | MEDLINE | ID: mdl-38678025

ABSTRACT

The black rat (Rattus rattus) is a globally invasive species that has been widely introduced across Africa. Within its invasive range in West Africa, R. rattus may compete with the native rodent Mastomys natalensis, the primary reservoir host of Lassa virus, a zoonotic pathogen that kills thousands annually. Here, we use rodent trapping data from Sierra Leone and Guinea to show that R. rattus presence reduces M. natalensis density within the human dwellings where Lassa virus exposure is most likely to occur. Further, we integrate infection data from M. natalensis to demonstrate that Lassa virus zoonotic spillover risk is lower at sites with R. rattus. While non-native species can have numerous negative effects on ecosystems, our results suggest that R. rattus invasion has the indirect benefit of decreasing zoonotic spillover of an endemic pathogen, with important implications for invasive species control across West Africa.


Subject(s)
Disease Reservoirs , Introduced Species , Lassa Fever , Lassa virus , Murinae , Zoonoses , Animals , Lassa virus/pathogenicity , Lassa virus/physiology , Lassa Fever/transmission , Lassa Fever/epidemiology , Lassa Fever/virology , Lassa Fever/veterinary , Disease Reservoirs/virology , Humans , Rats , Murinae/virology , Zoonoses/virology , Zoonoses/transmission , Zoonoses/epidemiology , Sierra Leone/epidemiology , Guinea/epidemiology , Ecosystem , Rodent Diseases/virology , Rodent Diseases/epidemiology , Rodent Diseases/transmission
13.
J Med Virol ; 96(5): e29621, 2024 May.
Article in English | MEDLINE | ID: mdl-38654686

ABSTRACT

Mpox is a zoonotic disease historically reported in Africa. Since 2003, limited outbreaks have occurred outside Africa. In 2022, the global spread of cases with sustained interhuman transmission and unusual disease features raised public health concerns. We explore the mpox outbreak in Rio de Janeiro (RJ) state, Brazil, in an observational study of mpox-suspected cases from June to December 2022. Data collection relied on a public healthcare notification form. Diagnosis was determined by MPXV-PCR. In 46 confirmed cases, anti-OPXV IgG was determined by ELISA, and seven MPXV genomes were sequenced. A total of 3095 cases were included, 816 (26.3%) with positive MPXV-PCR results. Most positive cases were men in their 30 s and MSM. A total of 285 (34.9%) MPXV-PCR+ patients live with HIV. Eight were coinfected with varicella-zoster virus. Anogenital lesions and adenomegaly were associated with the diagnosis of mpox. Females and individuals under 18 represented 9.4% and 5.4% of all confirmed cases, respectively, showing higher PCR cycle threshold (Ct) values and fewer anogenital lesions compared to adult men. Anti-OPXV IgG was detected in 29/46 (63.0%) patients. All analyzed sequences belonged to clade IIb. In RJ state, mpox presented a diverse clinical picture, represented mainly by mild cases with low complication rates and prominent genital involvement. The incidence in females and children was higher than usually reported. The observation of a bimodal distribution of Ct values, with few positive results, may suggest the need to review the diagnostic criteria in these groups.


Subject(s)
Disease Outbreaks , Humans , Brazil/epidemiology , Male , Female , Adult , Young Adult , Adolescent , Middle Aged , Animals , Zoonoses/epidemiology , Zoonoses/virology , Herpesvirus 3, Human/genetics , Herpesvirus 3, Human/isolation & purification , Child , HIV Infections/epidemiology , HIV Infections/virology , Antibodies, Viral/blood , Aged , Immunoglobulin G/blood
14.
Viruses ; 16(4)2024 04 16.
Article in English | MEDLINE | ID: mdl-38675958

ABSTRACT

Reverse zoonotic transmission events of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been described since the start of the pandemic, and the World Organisation for Animal Health (WOAH) designated the detection of SARS-CoV-2 in animals a reportable disease. Eighteen domestic and zoo animals in Great Britain and Jersey were tested by APHA for SARS-CoV-2 during 2020-2023. One domestic cat (Felis catus), three domestic dogs (Canis lupus familiaris), and three Amur tigers (Panthera tigris altaica) from a zoo were confirmed positive during 2020-2021 and reported to the WOAH. All seven positive animals were linked with known SARS-CoV-2 positive human contacts. Characterisation of the SARS-CoV-2 variants by genome sequencing indicated that the cat was infected with an early SARS-CoV-2 lineage. The three dogs and three tigers were infected with the SARS-CoV-2 Delta variant of concern (B.1.617.2). The role of non-human species in the onward transmission and emergence of new variants of SARS-CoV-2 remain poorly defined. Continued surveillance of SARS-CoV-2 in relevant domestic and captive animal species with high levels of human contact is important to monitor transmission at the human-animal interface and to assess their role as potential animal reservoirs.


Subject(s)
Animals, Zoo , COVID-19 , SARS-CoV-2 , Tigers , Animals , Dogs , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , SARS-CoV-2/classification , COVID-19/transmission , COVID-19/epidemiology , COVID-19/veterinary , COVID-19/virology , Tigers/virology , Cats , Animals, Zoo/virology , England/epidemiology , Humans , Phylogeny , Dog Diseases/virology , Dog Diseases/epidemiology , Dog Diseases/transmission , Zoonoses/virology , Zoonoses/transmission , Zoonoses/epidemiology
15.
Sci Total Environ ; 930: 172307, 2024 Jun 20.
Article in English | MEDLINE | ID: mdl-38599392

ABSTRACT

For canine parvovirus -2 (CPV-2), a zoonotic virus capable of cross-species transmission in animals, the amino acid changes of capsid protein VP2 are key factors when binding to other species' transferrin receptors (TfR). CPV-2 variants can spread from felines and canines, for example, to Carnivora, Artiodactyla, and Pholidota species, and CPV-2c variants are essential to spread from Carnivora to Artiodactyla and Pholidota species in particular. In our study, a CPV-2a variant maintained a relatively stable trend, and the proportion of CPV-2c gradually rose from 1980 to 2021. The VP2 amino acid sequence analysis showed that five amino acid mutations at 426E/D, 305H/D, and 297S may be necessary for the virus to bind to different host receptors. Meanwhile, receptor-binding loop regions and amino acid sites 87 L, 93 N, 232I, and 305Y were associated with CPV-2 cross-species transmission. The homology of TfRs in different hosts infected with CPV-2 ranged from 77.2 % to 99.0 %, and from pig to feline, canine, and humans was 80.7 %, 80.4 %, and 77.2 %, respectively. The amino acid residues of TfRs involved in the viral binding in those hosts are highly conserved, which suggests that CPV-2 may be capable of pig-to-human transmission. Our analysis of the origin, evolutionary trend, cross-species transmission dynamics, and genetic characteristics of CPV-2 when binding to host receptors provides a theoretical basis for further research on CPV-2's mechanism of cross-species transmission and for establishing an early warning and monitoring mechanism for the possible threat of CPV-2 to animal-human public security.


Subject(s)
Parvovirus, Canine , Parvovirus, Canine/genetics , Animals , Dogs , Humans , Parvoviridae Infections/veterinary , Parvoviridae Infections/transmission , Cats , Capsid Proteins/metabolism , Capsid Proteins/genetics , Zoonoses/virology , Zoonoses/transmission , Receptors, Transferrin/metabolism , Receptors, Transferrin/genetics
17.
Comp Immunol Microbiol Infect Dis ; 109: 102183, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38640700

ABSTRACT

Henipavirus (HNV) is well known for two zoonotic viruses in the genus, Hendra virus (HeV) and Nipah virus (NiV), which pose serious threat to human and animal health. In August 2022, a third zoonotic virus in the genus Henipavirus, Langya virus (LayV), was discovered in China. The emergence of HeV, NiV, and LayV highlights the persistent threat of HNV to human and animal health. In addition to the above three HNVs, new species within this genus are still being discovered. Although they have not yet caused a pandemic in humans or livestock, they still have the risk of spillover as a potential threat to the health of humans and animals. It's important to understand the infection and transmission of different HNV in animals for the prevention and control of current or future HNV epidemics. Therefore, this review mainly summarizes the animal origin, animal infection and transmission of HNV that have been found worldwide, and further analyzes and summarizes the rules of infection and transmission, so as to provide a reference for relevant scientific researchers. Furthermore, it can provide a direction for epidemic prevention and control, and animal surveillance to reduce the risk of the global pandemic of HNV.


Subject(s)
Henipavirus Infections , Henipavirus , Animals , Henipavirus Infections/transmission , Henipavirus Infections/epidemiology , Henipavirus Infections/veterinary , Henipavirus Infections/virology , Humans , Zoonoses/transmission , Zoonoses/virology , Viral Zoonoses/transmission , Viral Zoonoses/virology , Nipah Virus/pathogenicity , Hendra Virus
18.
Braz J Infect Dis ; 28(2): 103742, 2024.
Article in English | MEDLINE | ID: mdl-38670166

ABSTRACT

A substantial number of zoonotic diseases are caused by viral pathogens, representing a significant menace to public health, particularly to susceptible populations, such as pregnant women, the elderly, and immunocompromised individuals. Individuals who have undergone solid organ transplantation frequently experience immunosuppression, to prevent organ rejection, and, thus are more prone to opportunistic infections. Furthermore, the reactivation of dormant viruses can threaten transplant recipients and organ viability. This mini-review examines the up-to-date literature covering potential zoonotic and organ rejection-relevant viruses in solid organ transplant recipients. A comprehensive list of viruses with zoonotic potential is highlighted and the most important clinical outcomes in patients undergoing transplantation are described. Moreover, this mini-review calls attention to complex multifactorial events predisposing viral coinfections and the need for continuous health surveillance and research to understand better viral pathogens' transmission and pathophysiology dynamics in transplanted individuals.


Subject(s)
Immunocompromised Host , Organ Transplantation , Transplant Recipients , Humans , Organ Transplantation/adverse effects , Animals , Virus Diseases/transmission , Virus Diseases/virology , Disease Susceptibility , Zoonoses/transmission , Zoonoses/virology , Viral Zoonoses/transmission , Viral Zoonoses/virology , Risk Factors
19.
Ecohealth ; 21(1): 94-111, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38372845

ABSTRACT

Ecological information on wildlife reservoirs is fundamental for research targeting prevention of zoonotic infectious disease, yet basic information is lacking for many species in global hotspots of disease emergence. We provide the first estimates of synchronicity, magnitude, and timing of seasonal birthing in Mops condylurus, a putative ebolavirus host, and a co-roosting species, Mops pumilus (formerly Chaerephon pumilus). We show that population-level synchronicity of M. condylurus birthing is wide (~ 8.5 weeks) and even wider in M. pumilus (> 11 weeks). This is predicted to promote the likelihood of filovirus persistence under conditions of bi-annual birthing (two births per year). Ecological features underlying the magnitude of the birth pulse-relative female abundance (higher than expected for M. condylurus and lower for M. pumilus, based on literature) and reproductive rate (lower than expected)-will have countering effects on birthing magnitude. Species-specific models are needed to interpret how identified birth pulse attributes may interact with other features of molossid ebolavirus ecology to influence infection dynamics. As a common feature of wildlife species, and a key driver of infection dynamics, detailed information on seasonal birthing will be fundamental for future research on these species and will be informative for bat-borne zoonoses generally.


Subject(s)
Chiroptera , Seasons , Animals , Chiroptera/virology , Female , Kenya/epidemiology , Disease Reservoirs/virology , Hemorrhagic Fever, Ebola/epidemiology , Ebolavirus , Parturition , Zoonoses/virology
20.
Sci Data ; 10(1): 681, 2023 10 07.
Article in English | MEDLINE | ID: mdl-37805633

ABSTRACT

Zoonotic spillover of sarbecoviruses (SarbeCoVs) from non-human animals to humans under natural conditions has led to two large-scale pandemics, the severe acute respiratory syndrome (SARS) pandemic in 2003 and the ongoing COVID-19 pandemic. Knowledge of the genetic diversity, geographical distribution, and host specificity of SarbeCoVs is therefore of interest for pandemic surveillance and origin tracing of SARS-CoV and SARS-CoV-2. This study presents a comprehensive repository of publicly available animal-associated SarbeCoVs, covering 1,535 viruses identified from 63 animal species distributed in 43 countries worldwide (as of February 14,2023). Relevant meta-information, such as host species, sampling time and location, was manually curated and included in the dataset to facilitate further research on the potential patterns of viral diversity and ecological characteristics. In addition, the dataset also provides well-annotated sequence sets of receptor-binding domains (RBDs) and receptor-binding motifs (RBMs) for the scientific community to highlight the potential determinants of successful cross-species transmission that could be aid in risk estimation and strategic design for future emerging infectious disease control and prevention.


Subject(s)
Severe acute respiratory syndrome-related coronavirus , Zoonoses , Animals , Humans , COVID-19/virology , Zoonoses/virology , Severe Acute Respiratory Syndrome/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...